Loperamide Hydrochloride
NDC 68016-123, Loperamide Hydrochloride, tablet, from Chain Drug Consortium, LLC.
- Product NDC
- 68016-123
- Status
- Listed
- Labeler
- Chain Drug Consortium, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA074091
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68016-123 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LOPERAMIDE HYDROCHLORIDE2 mg/1
Pharmacologic classes
Opioid Agonist [EPC]; Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68016-123-06 | 68016012306 | 6 TABLET in 1 BLISTER PACK (68016-123-06) |
| 68016-123-18 | 68016012318 | 18 TABLET in 1 BLISTER PACK (68016-123-18) |
| 68016-123-24 | 68016012324 | 24 TABLET in 1 BLISTER PACK (68016-123-24) |
| 68016-123-97 | 68016012397 | 96 TABLET in 1 BOTTLE (68016-123-97) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 68016-123 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68016-123 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68016-123. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.